PT 141 vs Melanotan 2
A side-by-side research reference for PT 141 and Melanotan 2 — mechanism of action, catalogue data, and the key studies behind each compound.
| Comparison | ||
|---|---|---|
| Compound class | Peptides · Injectable vial | Peptides · Injectable vial |
| Mechanism of action | Cyclic heptapeptide melanocortin agonist selective for hypothalamic MC3R and MC4R — acts centrally rather than on peripheral vasculature. | Alpha-MSH analogue activating MC1R (melanogenesis), MC3R and MC4R (appetite and central arousal pathways). |
| Reference concentration | 10mg | 10mg |
| Research form | Injectable vial | Injectable vial |
Key studies on PT 141
Published literature for this compound is indexed on PubMed.
More comparisons
Research Use Only
All compounds referenced on this page are sold for in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. This page is for research and informational purposes only.

